A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Wednesday, July 22, 2026
Tag: therapeutic devices
GE’s Spinoff Deserves Healthy Skepticism
While GE HealthCare will deliver better growth as a stand-alone, the new company’s valuation looks stretched and its leverage is ...
WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen
Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth ...
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.